Is VTRS Worth Buying in 2026?

Viatris Inc. Common Stock

STOCK PHARMACEUTICAL PREPARATIONS Updated 2026-08-16

Here’s whether Viatris Inc. Common Stock (VTRS) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Neutral.

🔵
Neutral

Positives: trading above the 200-day MA (long-term uptrend intact); 50-day MA is rising (+0.60% over 10 days); strong 1-year return of +51.8%; rising volume confirms the move (1.22x 30d avg). Concerns: below the 50-day MA (medium-term momentum negative); RSI 25 — oversold. Currently 11.8% off its 52-week high. Score: +3/7.

Ready to act on this? 📈 Trade on Webull

VTRS is holding above its long-term 200-day MA ($14.27) but has slipped below the 50-day MA ($16.58), pointing to short-term weakness in an otherwise intact trend. An RSI of 24.9 has dropped into oversold territory, which has historically preceded short-term bounces. The 1-year return of +51.8% compares to +20.4% for SPY (beat the market by 31.4%).

$10,000 invested 1 year ago → $15,182 today
vs. S&P 500 (SPY) — same period beat market by 31.4%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

Above 200-day MA ($14.27)
Above 50-day MA ($16.58)
!RSI(14) neutral zone (30–70) — currently 24.9
Positive return (+51.8%)
!Within 10% of period high (−11.8%)
Period Range $16.23
$9.43 $18.39
RSI (14) 24.9
0 · OversoldOverbought · 100

Key Metrics

Price$16.23
Period Return+51.8%
Period High$18.39
Period Low$9.43
Drawdown−11.8%
MA-50$16.58
MA-200$14.27
RSI (14)24.9
Avg Volume (30d)10.4M
vs. SPYbeat by 31.4%
Return Rank#276 of 1252

Trade VTRS

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers